Published in Nat Rev Immunol on September 22, 2006
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell (2012) 4.86
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93
Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J (2009) 2.83
Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study. Neurology (2014) 2.66
Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol (2013) 2.65
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology (2013) 2.64
Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol (2008) 2.42
Retracted Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med (2012) 2.39
TNF-alpha and adipocyte biology. FEBS Lett (2007) 2.37
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol (Oxf) (2010) 2.24
Migraine and obesity: epidemiology, mechanisms, and implications. Headache (2009) 2.05
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry (2009) 2.01
The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol (2008) 2.00
Increased macrophage migration into adipose tissue in obese mice. Diabetes (2011) 1.98
Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab (2008) 1.96
Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology (2011) 1.94
A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis (2012) 1.90
Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis (2009) 1.78
The role of adiponectin in cancer: a review of current evidence. Endocr Rev (2012) 1.78
Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol (2010) 1.76
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst (2012) 1.74
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation (2008) 1.73
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes (2010) 1.71
Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int (2013) 1.71
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue. Cancer (2014) 1.71
Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med (2010) 1.70
Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol (2009) 1.65
Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev (2011) 1.65
Gain in adiposity across 15 years is associated with reduced gray matter volume in healthy women. Psychosom Med (2009) 1.60
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes (2009) 1.59
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest (2011) 1.55
Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest (2012) 1.55
Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis (2012) 1.52
Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA (2013) 1.51
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab (2009) 1.49
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.45
Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol (2015) 1.44
The impact of obesity on the immune response to infection. Proc Nutr Soc (2012) 1.41
Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol (2008) 1.40
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax (2012) 1.40
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med (2008) 1.38
PGC-1alpha in aging and anti-aging interventions. Biochim Biophys Acta (2009) 1.35
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes. PLoS One (2011) 1.34
Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol (2010) 1.34
The role of leptin in the respiratory system: an overview. Respir Res (2010) 1.30
Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair (2008) 1.30
Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) (2012) 1.29
Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther (2011) 1.26
Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol (2010) 1.26
Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol (2014) 1.25
Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev (2010) 1.25
Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr (2008) 1.25
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes (2013) 1.25
Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol (2011) 1.24
Dietary polyphenols and obesity. Nutrients (2010) 1.23
Ebf1-dependent control of the osteoblast and adipocyte lineages. Bone (2008) 1.23
Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther (2013) 1.22
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophr Bull (2008) 1.21
Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000. J Adolesc Health (2010) 1.20
Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2009) 1.19
Leptin and Inflammation. Curr Immunol Rev (2008) 1.19
Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res (2013) 1.19
Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol (2010) 1.18
Sleep duration and circulating adipokine levels. Sleep (2011) 1.18
Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. Am J Physiol Lung Cell Mol Physiol (2010) 1.18
The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J Immunol (2009) 1.17
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol (2012) 1.17
Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria. Am J Physiol Endocrinol Metab (2011) 1.17
Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci (2013) 1.15
Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) (2008) 1.15
Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem (2011) 1.14
Fat: a matter of disturbance for the immune system. World J Gastroenterol (2010) 1.13
Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes (2012) 1.13
Leptin, adiponectin and pulmonary diseases. Biochimie (2012) 1.11
Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr (2013) 1.11
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun (2014) 1.10
Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc (2015) 1.10
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Arthritis Res Ther (2010) 1.09
Adiposity, inflammation, and risk for death in black and white men and women in the United States: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Clin Endocrinol Metab (2011) 1.09
Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol (2013) 1.09
Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes (2011) 1.09
Inflammation in obesity-related diseases. Surgery (2008) 1.08
Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis (2009) 1.08
Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance. Diabetes (2010) 1.08
Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. Endocrinology (2010) 1.08
Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters. J Lipid Res (2012) 1.08
Role of adiponectin in metabolic and cardiovascular disease. J Exerc Rehabil (2014) 1.07
Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation. J Am Coll Surg (2013) 1.07
Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med (2011) 1.06
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology (2010) 4.76
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med (2013) 2.93
Inflammatory mechanisms in the regulation of insulin resistance. Mol Med (2008) 2.71
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity (2011) 2.20
Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab (2008) 2.12
Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) (2008) 1.52
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
Obesity and the microbiota. Gastroenterology (2009) 1.49
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26
Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) (2013) 1.08
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol (2005) 1.07
Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol (2005) 1.04
How to modulate inflammatory cytokines in liver diseases. Liver Int (2006) 1.02
Pathways of liver injury in alcoholic liver disease. J Hepatol (2011) 0.97
Visceral adipose tissue attacks beyond the liver: esophagogastric junction as a new target. Gastroenterology (2010) 0.95
Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver. Can J Physiol Pharmacol (2013) 0.86
The role of lipocalin-2 in liver regeneration. Liver Int (2014) 0.84
IL-1 cytokine family members and NAFLD: neglected in metabolic liver inflammation. J Hepatol (2011) 0.84
Evolving therapies for non-alcoholic steatohepatitis. Expert Opin Drug Discov (2014) 0.82
Adipocytokines and hepatocellular carcinoma. Dig Dis (2012) 0.81
Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression? Eur Cytokine Netw (2009) 0.81
Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int (2013) 0.78
Malnutrition and microbiota--a new relationship? Nat Rev Gastroenterol Hepatol (2013) 0.77
Proinflammatory wheat attacks on the intestine: alpha-amylase trypsin inhibitors as new players. Gastroenterology (2013) 0.76
Corrigendum: IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun (2015) 0.75
Relevance of TNF-α gene polymorphisms in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol (2011) 0.75